← All indications
Spondylarthritis
Inflammation of the joints of the SPINE, the intervertebral articulations.
Subtype terms (2)
More specific conditions that are subtypes of Spondylarthritis in the MeSH hierarchy.
- Osteoarthritis, Spine
4 drugs (3 approved, 1 experimental)
- Spondylarthropathies
17 drugs (15 approved, 2 experimental)
Drugs by status
Phase 4 trials (8)
Phase 3 trials (1)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (33)
- Abbott
- AbbVie
- Centocor
- Merck
- Pfizer
- Novartis
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Region Skane
- Aarhus University
- Diakonhjemmet Hospital
- Gottfried Wilhelm Leibniz Universität Hannover
- Hoosier Cancer Research Network
- Rheumatism Foundation Hospital
- University of Alberta
- Columbia University
- Sohag University
- University of Copenhagen
- Bangladesh Medical University
- Southern Medical University
- South Korea Army
- University of Lyon
- Sun Yat-Sen University
- University of Sao Paulo
- Tuen Mun Hospital, Hong Kong
- Hospitalsenhed Midt
- South-Eastern Norway Regional Health Authority
- Improvement by Movement GmbH, Germany
- IST GmbH, Germany
- Orion Corporation
- Central Denmark Region
- +3 more
Organization Involved with Phase 3 Indications (17)
- UCB
- Celgene
- Schering-Plough
- Eli Lilly
- Kyowa Hakko Kirin
- Sun Pharmaceuticals
- AIDS Malignancy Consortium
- Guangzhou Medical University
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- University of Amsterdam
- Pharmaceutical Research Associates, Inc. (PRA)
- Janssen Pharmaceutica NV
- Universitair Ziekenhuis Gent
- National Autonomous University of Mexico
- Ghent University
- the Flanders Institute for Biotechnology
- Globe Pharmaceuticals
Organization Involved with Phase 2 Indications (12)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (7)